McKesson Corporation to Announce Second Quarter Fiscal 2022 Results on November 1, 2021

On September 27, 2021 McKesson Corporation (NYSE: MCK) reported that it will release its second quarter fiscal 2022 financial results after market close on Monday, November 1, 2021 (Press release, McKesson, SEP 27, 2021, View Source [SID1234590335]). The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

The live webcast will be available on McKesson’s Investor Relations website at View Source, along with the company’s earnings press release, financial tables, and slide presentation.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!